WO2004026055A2 - Medical fabrics with improved barrier performance - Google Patents

Medical fabrics with improved barrier performance Download PDF

Info

Publication number
WO2004026055A2
WO2004026055A2 PCT/US2003/029713 US0329713W WO2004026055A2 WO 2004026055 A2 WO2004026055 A2 WO 2004026055A2 US 0329713 W US0329713 W US 0329713W WO 2004026055 A2 WO2004026055 A2 WO 2004026055A2
Authority
WO
WIPO (PCT)
Prior art keywords
barrier
denier
nano
fabrics
nonwoven
Prior art date
Application number
PCT/US2003/029713
Other languages
French (fr)
Other versions
WO2004026055A3 (en
Inventor
Jerry Zucker
Nick Mark Carter
Original Assignee
Polymer Group Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymer Group Inc. filed Critical Polymer Group Inc.
Priority to JP2004538352A priority Critical patent/JP2005539158A/en
Priority to MXPA05003031A priority patent/MXPA05003031A/en
Priority to AU2003275082A priority patent/AU2003275082A1/en
Priority to EP03759352A priority patent/EP1549161A4/en
Publication of WO2004026055A2 publication Critical patent/WO2004026055A2/en
Publication of WO2004026055A3 publication Critical patent/WO2004026055A3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/30Woven fabric [i.e., woven strand or strip material]

Definitions

  • the present invention relates generally to medical fabrics, and more specifically, to medical gowns and drapes comprised of nonwoven compound fabrics with improved barrier performance relative to basis weight, wherein the improved nonwoven compound fabrics are prepared by supplying a strong and durable substrate layer followed by deposition of a nano-denier, essentially continuous filament barrier layer onto the substrate layer thereby providing nonwoven barrier materials, which exhibit enhanced barrier performance in comparison to conventional medical gowns and drapes.
  • Nonwoven fabric constructs are used in a very wide variety of applications in which the engineered qualities of such materials can be advantageously employed.
  • Nonwoven fabric webs may be formed from fibrous material in the form of natural or synthetic fibers, or substantially continuous filaments, with the materials from which such fabrics are formed, and the nature of the fabrication process, determining the physical characteristics of the resultant fabric.
  • Nonwoven fabric constructs may include plural or composite fabric layers, and may also include composite structures formed from laminations of nonwoven fabrics and polymeric films.
  • Nonwoven fabric constructs have proven to be particularly suitable for a variety of medical applications since they permit cost-effective, disposable use. Use of such materials for medical gowns and the like has become increasingly widespread, since the physical properties and characteristics of the nonwoven fabric constructs can be selected as may be required for specific medical applications.
  • nonwoven fabric construct functions as a fluidic barrier, so that clothing formed from such a material provides the necessary protection against blood, body fluids, and other potentially infectious materials.
  • nonwoven fabric materials in the form of nonwoven laminates have been used in the past, such materials have typically included internally or topically treated conventional spunbond/meltblown/spunbond (SMS) fabrics and the like.
  • SMS spunbond/meltblown/spunbond
  • the present nonwoven fabric construct is intended to provide improved barrier protection, thereby facilitating use of the material for medical applications, specifically gowns and drapes, with the present material lending itself to cost-effective, disposable use.
  • the present invention is directed to medical fabrics, and more specifically, to medical gowns and drapes comprised of nonwoven compound fabrics with improved barrier performance relative to basis weight, wherein the improved nonwoven compound fabrics are prepared by supplying a strong and durable substrate layer followed by deposition of a nano-denier, essentially continuously filament barrier layer onto the substrate layer thereby providing nonwoven barrier materials, which exhibit enhanced barrier performance in comparison to conventional medical gowns and drapes.
  • a barrier layer preferentially comprising nano-fibers of infinite length, wherein the average fiber diameter of the nano-fiber is in the range of less than or equal to 1000 nanometers, and preferably less than or equal to 500 nanometers, is applied to at least one substrate layer.
  • Said substrate layer or layers and said nano-fiber layer layers, and optionally one or more secondary barrier materials, are consolidated into a single compound fabric.
  • thermoplastic polymers of the nano-denier continuous filament barrier are chosen from the group consisting of polyolefins, polyamides, and polyesters, wherein the polyolefins are chosen from the group consisting of polypropylene, polyethylene, and combinations thereof. It is within the purview of the present invention that the nano-denier, continuous filament barrier layer or layers may comprise either the same or different thermoplastic polymers. Further, the nano-denier continuous filaments of the barrier layer or layers may comprise homogeneous, bicomponent, and/or multi-component profiles, as well as, performance modifying additives, and the blends thereof.
  • the strong and durable substrate layer comprises a material selected from suitable media, such media being represented by, but not limited to: continuous filament nonwoven fabrics, staple fiber nonwoven fabrics, continuous filament or staple fiber woven textiles, and films.
  • suitable media such media being represented by, but not limited to: continuous filament nonwoven fabrics, staple fiber nonwoven fabrics, continuous filament or staple fiber woven textiles, and films.
  • the composition of the substrate layer may be selected from synthetic and natural materials and the blends thereof.
  • the incorporation of one or more nano-denier barrier layers provide substantial improvement in barrier function, allowing for reduction in the total amount of the substrate and /or barrier layer required to meet barrier performance criteria.
  • a further aspect of the present invention is directed to the nano-denier barrier layer providing a more uniform support layer for subsequently applied barrier layers or substrate layers during the manufacturing process, thus providing an improvement in barrier function of the resulting medical fabric.
  • the present invention allows for the production of a same weight fabric with improved barrier properties or a lighter weight fabric that is suitable for use as a barrier fabric, particularly for medical applications, such as disposable gowns and drapes.
  • the present invention is directed to medical gowns and drapes with an improved barrier performance due to the incorporation of nano-denier continuous filaments and at least one substrate layer of strong and durable material.
  • the nano-denier continuous filaments preferably have a denier of less than or equal to 1000 nanometers, and preferably have a denier less than or equal to about 500 nanometers.
  • Suitable nano-denier continuous filament barrier layers can be formed by either direct spinning of nano-denier filaments or by formation of a multi- component filament that is divided into nano-denier filaments prior to deposition on a substrate layer.
  • Multi-component filament spinning with integrated division into nano-denier filaments can be practiced in accordance with the teachings of U.S. Patent No. 's 5,225,018 and 5,783,503, both incorporated herein by reference.
  • Fibers and/or filaments comprising the strong and durable substrate layer are selected from natural or synthetic composition, of homogeneous or mixed fiber length. Suitable natural fibers include, but are not limited to, cotton, wood pulp and viscose rayon. Synthetic fibers, which may be blended in whole or part, include thermoplastic and thermoset polymers. Thermoplastic polymers suitable for blending with thermoplastic resins include polyolefins, polyamides and polyesters. The thermoplastic polymers may be further selected from homopolymers; copolymers, conjugates and other derivatives including those thermoplastic polymers having incorporated melt additives or surface-active agents.
  • continuous filament nonwoven fabric formation involves the practice of the spunbond process.
  • a spunbond process involves supplying a molten polymer, which is then extruded under pressure through a large number of orifices in a plate known as a spinneret or die.
  • the resulting continuous filaments are quenched and drawn by any of a number of methods, such as slot draw systems, attenuator guns, or Godet rolls.
  • the continuous filaments are collected as a loose web upon a moving foraminous surface, such as a wire mesh conveyor belt.
  • the subsequent webs are collected upon the uppermost surface of the previously formed web.
  • the web is then at least temporarily consolidated, usually by means involving heat and pressure, such as by thermal point bonding.
  • the web or layers of webs are passed between two hot metal rolls, one of which has an embossed pattern to impart and achieve the desired degree of point bonding, usually on the order of 10 to 40 percent of the overall surface area being so bonded.
  • Staple fibers used to form nonwoven fabrics begin in a bundled form as a bale of compressed fibers.
  • the bale is bulk-fed into a number of fiber openers, such as a garnet, then into a card.
  • the card further frees the fibers by the use of co-rotational and counter-rotational wire combs, then deposits the fibers into a lofty batt.
  • the lofty batt of staple fibers can then optionally be subjected to fiber reorientation, such as by air- randomization and/or cross-lapping, depending upon the ultimate tensile properties of the resulting nonwoven fabric desired.
  • the fibrous batt is integrated into a nonwoven fabric by application of suitable bonding means, including, but not limited to, use of adhesive binders, thermobonding by calender or through-air oven, and hydroentanglement.
  • the production of conventional textile fabrics is known to be a complex, multi-step process.
  • the production of staple fiber yarns involves the carding of the fibers to provide feedstock for a roving machine, which twists the bundled fibers into a roving yarn.
  • continuous filaments are formed into bundle known as a tow, the tow then serving as a component of the roving yarn.
  • Spinning machines blend multiple roving yarns into yarns that are suitable for the weaving of cloth.
  • a first subset of weaving yarns is transferred to a warp beam, which, in turn, contains the machine direction yarns, which will then feed into a loom.
  • a second subset of weaving yarns supply the weft or fill yarns which are the cross direction threads in a sheet of cloth.
  • commercial high-speed looms operate at a speed of 1000 - 1500 picks per minute, whereby each pick is a single yarn.
  • the weaving process produces the final fabric at manufacturing speeds of 60 inches to 200 inches per minute.
  • thermoplastic polymers suitable as a strong and durable substrate layer
  • Thermoplastic polymer films can be formed by either dispersion of a quantity of molten polymer into a mold having the dimensions of the desired end product, known as a cast film, or by continuously forcing the molten polymer through a die, known as an extruded film.
  • Extruded thermoplastic polymer films can either be formed such that the film is cooled then wound as a completed material, or dispensed directly onto a secondary substrate material to form a composite material having performance of both the substrate and the film layers.
  • suitable secondary substrate materials include other films, polymeric or metallic sheet stock, and woven or nonwoven fabrics.
  • Extruded films utilizing the composition of the present invention can be formed in accordance with the following representative direct extrusion film process.
  • Blending and dosing storage comprising at least one hopper loader for thermoplastic polymer chip and, optionally, one for pelletized additive in thermoplastic carrier resin, feed into variable speed augers.
  • the variable speed augers transfer predetermined amounts of polymer chip and additive pellet into a mixing hopper.
  • the mixing hopper contains a mixing propeller to further the homogeneity of the mixture.
  • Basic volumetric systems such as that described are a minimum requirement for accurately blending the additive into the thermoplastic polymer.
  • the polymer chip and additive pellet blend feeds into a multi-zone extruder.
  • the polymer compound Upon mixing and extrusion from the multi-zone extruder, the polymer compound is conveyed via heated polymer piping through a screen changer, wherein breaker plates having different screen meshes are employed to retain solid or semi-molten polymer chips and other macroscopic debris.
  • the mixed polymer is then fed into a melt pump, and then to a combining block.
  • the combining block allows for multiple film layers to be extruded, the film layers being of either the same composition or fed from different systems as described above.
  • the combining block is connected to an extrusion die, which is positioned in an overhead orientation such that molten film extrusion is deposited at a nip between a nip roll and a cast roll.
  • a secondary substrate material source is provided in roll form to a tension-controlled unwinder.
  • the secondary substrate material is unwound and moves over the nip roll.
  • the molten film extrusion from the extrusion die is deposited onto the secondary substrate material at the nip point between the nip roll and the cast roll to form a strong and durable substrate layer.
  • the newly formed substrate layer is then removed from the cast roll by a stripper roll and wound onto a new roll.
  • a secondary barrier material can be combined with the nano-denier barrier layer.
  • Suitable secondary barrier materials can be selected from such representative materials as: meltblown fibers, microporous films and monolithic films.
  • a related means to the spunbond process for forming a layer of a nonwoven fabric is the meltblown process. Again, a molten polymer is extruded under pressure through orifices in a spinneret or die. High velocity air impinges upon and entrains the filaments as they exit the die. The energy of this step is such that the formed filaments are greatly reduced in diameter and are fractured so that microfibers of finite length are produced. This differs from the spunbond process whereby the continuity of the filaments is preserved.
  • the process to form either a single layer or a multiple-layer fabric is continuous, that is, the process steps are uninterrupted from extrusion of the filaments to form the first layer until the bonded web is wound into a roll.
  • a finer denier fabric will give a greater number of filaments and a smaller average pore size per unit area. The smaller average pore size will result in a more uniform deposition of the secondary barrier material onto the nano-denier barrier layer. A more uniform secondary barrier layer will also have fewer weak points in the web at which a failure in barrier performance can occur.
  • the nano-denier barrier layer also serves to support the secondary barrier layer structurally in the compound nonwoven material.
  • a nano-denier barrier layer provides a smaller average pore size and a larger number of support points for the secondary barrier layer, this results in shorter spans of unsupported secondary barrier material.
  • This mechanism embodies the well-known concept that reduction in the average span length results in enhanced structural integrity.
  • Manufacture of nonwoven compound fabrics embodying the principles of the present invention includes the use of fibers and/or filaments having different composition. Differing thermoplastic polymers can be compounded with the same or different performance improvement additives. Further, fibers and/or filaments may be blended with fibers and/or filaments that have not been modified by the compounding of additives.
  • Disposable medical fabrics such as gowns, drapes, wraps, and dressings are generally described in U.S. Patent Nos. 3,824,625, No. 3,935,596, No. 4,290,148, No. 3,934,582, No. 3,955,569, No. 4,166,461 , and No. 4,166,464, which are incorporated herein by reference.
  • Such gowns are usually comprised of a frontside and a backside, wherein either one side or the other is open for the purpose of donning the disposable garment, which is then usually tied closed.
  • gowns are comprised of two sleeves and may optionally include wrist cuffs.

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Nonwoven Fabrics (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Laminated Bodies (AREA)

Abstract

The present invention is directed to medical fabrics, and more specifically, to medical gowns and drapes comprised of nonwoven compound fabrics with improved barrier performance relative to basis weight, wherein the improved nonwoven compound fabrics are prepared by supplying a strong and durable substrate layer followed by deposition of a nano-denier, essentially continuously filament barrier layer onto the substrate layer thereby providing nonwoven barrier materials, which exhibit enhanced barrier performance in comparison to conventional medical gowns and drapes.

Description

Medical Fabrics With Improved Barrier Performance Technical Field
The present invention relates generally to medical fabrics, and more specifically, to medical gowns and drapes comprised of nonwoven compound fabrics with improved barrier performance relative to basis weight, wherein the improved nonwoven compound fabrics are prepared by supplying a strong and durable substrate layer followed by deposition of a nano-denier, essentially continuous filament barrier layer onto the substrate layer thereby providing nonwoven barrier materials, which exhibit enhanced barrier performance in comparison to conventional medical gowns and drapes.
Background of the Invention
Nonwoven fabric constructs are used in a very wide variety of applications in which the engineered qualities of such materials can be advantageously employed. Nonwoven fabric webs may be formed from fibrous material in the form of natural or synthetic fibers, or substantially continuous filaments, with the materials from which such fabrics are formed, and the nature of the fabrication process, determining the physical characteristics of the resultant fabric.
Nonwoven fabric constructs may include plural or composite fabric layers, and may also include composite structures formed from laminations of nonwoven fabrics and polymeric films.
Nonwoven fabric constructs have proven to be particularly suitable for a variety of medical applications since they permit cost-effective, disposable use. Use of such materials for medical gowns and the like has become increasingly widespread, since the physical properties and characteristics of the nonwoven fabric constructs can be selected as may be required for specific medical applications.
For protective medical applications, it is important that a nonwoven fabric construct functions as a fluidic barrier, so that clothing formed from such a material provides the necessary protection against blood, body fluids, and other potentially infectious materials. While nonwoven fabric materials in the form of nonwoven laminates have been used in the past, such materials have typically included internally or topically treated conventional spunbond/meltblown/spunbond (SMS) fabrics and the like. The present nonwoven fabric construct is intended to provide improved barrier protection, thereby facilitating use of the material for medical applications, specifically gowns and drapes, with the present material lending itself to cost-effective, disposable use. Summary of the Invention The present invention is directed to medical fabrics, and more specifically, to medical gowns and drapes comprised of nonwoven compound fabrics with improved barrier performance relative to basis weight, wherein the improved nonwoven compound fabrics are prepared by supplying a strong and durable substrate layer followed by deposition of a nano-denier, essentially continuously filament barrier layer onto the substrate layer thereby providing nonwoven barrier materials, which exhibit enhanced barrier performance in comparison to conventional medical gowns and drapes.
A barrier layer preferentially comprising nano-fibers of infinite length, wherein the average fiber diameter of the nano-fiber is in the range of less than or equal to 1000 nanometers, and preferably less than or equal to 500 nanometers, is applied to at least one substrate layer. Said substrate layer or layers and said nano-fiber layer layers, and optionally one or more secondary barrier materials, are consolidated into a single compound fabric.
The thermoplastic polymers of the nano-denier continuous filament barrier are chosen from the group consisting of polyolefins, polyamides, and polyesters, wherein the polyolefins are chosen from the group consisting of polypropylene, polyethylene, and combinations thereof. It is within the purview of the present invention that the nano-denier, continuous filament barrier layer or layers may comprise either the same or different thermoplastic polymers. Further, the nano-denier continuous filaments of the barrier layer or layers may comprise homogeneous, bicomponent, and/or multi-component profiles, as well as, performance modifying additives, and the blends thereof.
The strong and durable substrate layer comprises a material selected from suitable media, such media being represented by, but not limited to: continuous filament nonwoven fabrics, staple fiber nonwoven fabrics, continuous filament or staple fiber woven textiles, and films. The composition of the substrate layer may be selected from synthetic and natural materials and the blends thereof. In a fabric formed in accordance with the present invention, the incorporation of one or more nano-denier barrier layers provide substantial improvement in barrier function, allowing for reduction in the total amount of the substrate and /or barrier layer required to meet barrier performance criteria.
A further aspect of the present invention is directed to the nano-denier barrier layer providing a more uniform support layer for subsequently applied barrier layers or substrate layers during the manufacturing process, thus providing an improvement in barrier function of the resulting medical fabric. Formation of fabrics from nano-denier barrier materials, particularly when a light basis weight nano-denier barrier layer is either coated or "dusted" onto a substrate layer or is combined with one or more conventional barrier layers, can provide enhanced barrier properties. The present invention allows for the production of a same weight fabric with improved barrier properties or a lighter weight fabric that is suitable for use as a barrier fabric, particularly for medical applications, such as disposable gowns and drapes.
Other features and advantages of the present invention will become readily apparent from the following detailed description, the accompanying drawings, and the appended claims. Detailed Description
While the present invention is susceptible of embodiment in various forms, there will hereinafter be described, presently preferred embodiments, with the understanding that the present disclosure is to be considered as an exemplification of the invention, and is not intended to limit the invention to the specific embodiments disclosed herein.
The present invention is directed to medical gowns and drapes with an improved barrier performance due to the incorporation of nano-denier continuous filaments and at least one substrate layer of strong and durable material. In order to achieve desired barrier properties to weight ratios for the compound structure, the nano-denier continuous filaments preferably have a denier of less than or equal to 1000 nanometers, and preferably have a denier less than or equal to about 500 nanometers. Suitable nano-denier continuous filament barrier layers can be formed by either direct spinning of nano-denier filaments or by formation of a multi- component filament that is divided into nano-denier filaments prior to deposition on a substrate layer. U.S. Patent No.'s 5,678,379 and 6,114,017, both incorporated herein by reference, exemplify direct spinning processes practicable in support of the present invention. Multi-component filament spinning with integrated division into nano-denier filaments can be practiced in accordance with the teachings of U.S. Patent No. 's 5,225,018 and 5,783,503, both incorporated herein by reference.
Technologies capable of forming a strong and durable substrate layer include those which form continuous filament nonwoven fabrics, staple fiber nonwoven fabrics, continuous filament or staple fiber woven textiles (to include knits), and films. A substrate is determined to be strong and durable based upon the substrate having sufficient physical properties to withstand manufacturing and fabrication processes. Fibers and/or filaments comprising the strong and durable substrate layer are selected from natural or synthetic composition, of homogeneous or mixed fiber length. Suitable natural fibers include, but are not limited to, cotton, wood pulp and viscose rayon. Synthetic fibers, which may be blended in whole or part, include thermoplastic and thermoset polymers. Thermoplastic polymers suitable for blending with thermoplastic resins include polyolefins, polyamides and polyesters. The thermoplastic polymers may be further selected from homopolymers; copolymers, conjugates and other derivatives including those thermoplastic polymers having incorporated melt additives or surface-active agents.
In general, continuous filament nonwoven fabric formation involves the practice of the spunbond process. A spunbond process involves supplying a molten polymer, which is then extruded under pressure through a large number of orifices in a plate known as a spinneret or die. The resulting continuous filaments are quenched and drawn by any of a number of methods, such as slot draw systems, attenuator guns, or Godet rolls. The continuous filaments are collected as a loose web upon a moving foraminous surface, such as a wire mesh conveyor belt. When more than one spinneret is used in line for the purpose of forming a multi-layered fabric, the subsequent webs are collected upon the uppermost surface of the previously formed web. The web is then at least temporarily consolidated, usually by means involving heat and pressure, such as by thermal point bonding. Using this means, the web or layers of webs are passed between two hot metal rolls, one of which has an embossed pattern to impart and achieve the desired degree of point bonding, usually on the order of 10 to 40 percent of the overall surface area being so bonded. Staple fibers used to form nonwoven fabrics begin in a bundled form as a bale of compressed fibers. In order to decompress the fibers, and render the fibers suitable for integration into a nonwoven fabric, the bale is bulk-fed into a number of fiber openers, such as a garnet, then into a card. The card further frees the fibers by the use of co-rotational and counter-rotational wire combs, then deposits the fibers into a lofty batt. The lofty batt of staple fibers can then optionally be subjected to fiber reorientation, such as by air- randomization and/or cross-lapping, depending upon the ultimate tensile properties of the resulting nonwoven fabric desired. The fibrous batt is integrated into a nonwoven fabric by application of suitable bonding means, including, but not limited to, use of adhesive binders, thermobonding by calender or through-air oven, and hydroentanglement.
The production of conventional textile fabrics is known to be a complex, multi-step process. The production of staple fiber yarns involves the carding of the fibers to provide feedstock for a roving machine, which twists the bundled fibers into a roving yarn. Alternately, continuous filaments are formed into bundle known as a tow, the tow then serving as a component of the roving yarn. Spinning machines blend multiple roving yarns into yarns that are suitable for the weaving of cloth. A first subset of weaving yarns is transferred to a warp beam, which, in turn, contains the machine direction yarns, which will then feed into a loom. A second subset of weaving yarns supply the weft or fill yarns which are the cross direction threads in a sheet of cloth. Currently, commercial high-speed looms operate at a speed of 1000 - 1500 picks per minute, whereby each pick is a single yarn. The weaving process produces the final fabric at manufacturing speeds of 60 inches to 200 inches per minute.
The formation of finite thickness films from thermoplastic polymers, suitable as a strong and durable substrate layer, is a well-known practice. Thermoplastic polymer films can be formed by either dispersion of a quantity of molten polymer into a mold having the dimensions of the desired end product, known as a cast film, or by continuously forcing the molten polymer through a die, known as an extruded film. Extruded thermoplastic polymer films can either be formed such that the film is cooled then wound as a completed material, or dispensed directly onto a secondary substrate material to form a composite material having performance of both the substrate and the film layers. Examples of suitable secondary substrate materials include other films, polymeric or metallic sheet stock, and woven or nonwoven fabrics.
Extruded films utilizing the composition of the present invention can be formed in accordance with the following representative direct extrusion film process. Blending and dosing storage comprising at least one hopper loader for thermoplastic polymer chip and, optionally, one for pelletized additive in thermoplastic carrier resin, feed into variable speed augers. The variable speed augers transfer predetermined amounts of polymer chip and additive pellet into a mixing hopper. The mixing hopper contains a mixing propeller to further the homogeneity of the mixture. Basic volumetric systems such as that described are a minimum requirement for accurately blending the additive into the thermoplastic polymer. The polymer chip and additive pellet blend feeds into a multi-zone extruder. Upon mixing and extrusion from the multi-zone extruder, the polymer compound is conveyed via heated polymer piping through a screen changer, wherein breaker plates having different screen meshes are employed to retain solid or semi-molten polymer chips and other macroscopic debris. The mixed polymer is then fed into a melt pump, and then to a combining block. The combining block allows for multiple film layers to be extruded, the film layers being of either the same composition or fed from different systems as described above. The combining block is connected to an extrusion die, which is positioned in an overhead orientation such that molten film extrusion is deposited at a nip between a nip roll and a cast roll.
When a secondary substrate material is to receive a film layer extrusion, a secondary substrate material source is provided in roll form to a tension-controlled unwinder. The secondary substrate material is unwound and moves over the nip roll. The molten film extrusion from the extrusion die is deposited onto the secondary substrate material at the nip point between the nip roll and the cast roll to form a strong and durable substrate layer. The newly formed substrate layer is then removed from the cast roll by a stripper roll and wound onto a new roll.
It is within the purview of the present invention that a secondary barrier material can be combined with the nano-denier barrier layer. Suitable secondary barrier materials can be selected from such representative materials as: meltblown fibers, microporous films and monolithic films. A related means to the spunbond process for forming a layer of a nonwoven fabric is the meltblown process. Again, a molten polymer is extruded under pressure through orifices in a spinneret or die. High velocity air impinges upon and entrains the filaments as they exit the die. The energy of this step is such that the formed filaments are greatly reduced in diameter and are fractured so that microfibers of finite length are produced. This differs from the spunbond process whereby the continuity of the filaments is preserved. The process to form either a single layer or a multiple-layer fabric is continuous, that is, the process steps are uninterrupted from extrusion of the filaments to form the first layer until the bonded web is wound into a roll.
Methods for producing these types of fabrics are described in U.S. Patent No. 4,041,203. The meltblown process, as well as the cross-sectional profile of the spunbond filament or meltblown microfiber, is not a critical limitation to the practice of the present invention. Breathable barrier films can be combined with the improved barrier performance imparted by combining the breathable barrier film with nano- denier continuous filaments. Monolithic films, as taught in patent number U.S. 6,191,211, and microporous films, as taught in patent number U.S. 6,264,864, both patents herein incorporated by reference, represent the mechanisms of forming such breathable barrier films.
It is believed that by providing a nano-denier continuous layer upon which a subsequent secondary barrier layer may deposited, several enhancements of the fabric can be realized. For a given basis weight of the spunbond layer, a finer denier fabric will give a greater number of filaments and a smaller average pore size per unit area. The smaller average pore size will result in a more uniform deposition of the secondary barrier material onto the nano-denier barrier layer. A more uniform secondary barrier layer will also have fewer weak points in the web at which a failure in barrier performance can occur. The nano-denier barrier layer also serves to support the secondary barrier layer structurally in the compound nonwoven material. A nano-denier barrier layer provides a smaller average pore size and a larger number of support points for the secondary barrier layer, this results in shorter spans of unsupported secondary barrier material. This mechanism embodies the well-known concept that reduction in the average span length results in enhanced structural integrity.
Manufacture of nonwoven compound fabrics embodying the principles of the present invention includes the use of fibers and/or filaments having different composition. Differing thermoplastic polymers can be compounded with the same or different performance improvement additives. Further, fibers and/or filaments may be blended with fibers and/or filaments that have not been modified by the compounding of additives.
Utilizing the above-discussed substrate and barrier layer manufacturing technologies, combinations of different constructs can be combined with a nano-denier barrier layer to yield compound nonwoven materials of further improved barrier performance. Such a performance is desirable among medical fabrics, specifically gowns and drapes.
Disposable medical fabrics, such as gowns, drapes, wraps, and dressings are generally described in U.S. Patent Nos. 3,824,625, No. 3,935,596, No. 4,290,148, No. 3,934,582, No. 3,955,569, No. 4,166,461 , and No. 4,166,464, which are incorporated herein by reference. Such gowns are usually comprised of a frontside and a backside, wherein either one side or the other is open for the purpose of donning the disposable garment, which is then usually tied closed. Further, gowns are comprised of two sleeves and may optionally include wrist cuffs. Practical application of an improved barrier fabric comprising a nano- denier barrier layer as described in this invention for a medical gown, results in a gown that is lighter in weight while maintaining performance. A lighter weight material is expected to be more flexible and therefore more conforming to deformation of the overall structure as the gown is applied and worn. From the foregoing, numerous modifications and variations can be effected without departing from the true spirit and scope of the novel concept of the present invention. It is to be understood that no limitation with respect to the specific embodiments disclosed herein is intended or should be inferred. The disclosure is intended to cover, by the appended claims, all such modifications as fall within the scope of the claims.

Claims

What Is Claimed Is:
1. A medical gown, comprising a nonwoven compound fabric, said nonwoven compound fabric comprises a nano-denier barrier layer comprising a plurality of continuous thermoplastic filaments having a denier of less than about 1000 nanometers, a secondary barrier layer, and a substrate layer.
2. A medical drape, comprising a nonwoven compound fabric, said nonwoven compound fabric comprises a nano-denier barrier layer comprising a plurality of continuous thermoplastic filaments having a denier of less than about 1000 nanometers, a secondary barrier layer, and a substrate layer.
PCT/US2003/029713 2002-09-18 2003-09-18 Medical fabrics with improved barrier performance WO2004026055A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2004538352A JP2005539158A (en) 2002-09-18 2003-09-18 Medical textile fabric with improved barrier performance
MXPA05003031A MXPA05003031A (en) 2002-09-18 2003-09-18 Medical fabrics with improved barrier performance.
AU2003275082A AU2003275082A1 (en) 2002-09-18 2003-09-18 Medical fabrics with improved barrier performance
EP03759352A EP1549161A4 (en) 2002-09-18 2003-09-18 Medical fabrics with improved barrier performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41164602P 2002-09-18 2002-09-18
US60/411,646 2002-09-18

Publications (2)

Publication Number Publication Date
WO2004026055A2 true WO2004026055A2 (en) 2004-04-01
WO2004026055A3 WO2004026055A3 (en) 2005-05-12

Family

ID=32030701

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/029713 WO2004026055A2 (en) 2002-09-18 2003-09-18 Medical fabrics with improved barrier performance

Country Status (7)

Country Link
US (2) US20040128732A1 (en)
EP (1) EP1549161A4 (en)
JP (1) JP2005539158A (en)
CN (1) CN1700865A (en)
AU (1) AU2003275082A1 (en)
MX (1) MXPA05003031A (en)
WO (1) WO2004026055A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011103351U1 (en) 2011-04-28 2011-11-02 Česká Včela s.r.o. barrier textiles
US8658548B2 (en) 2002-09-17 2014-02-25 E I Du Pont De Nemours And Company Extremely high liquid barrier fabrics

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1549790A4 (en) * 2002-09-19 2007-01-31 Polymer Group Inc Nonwoven industrial fabrics with improved barrier properties
WO2004092471A2 (en) * 2003-04-11 2004-10-28 Polymer Group, Inc. Hydroentangled continuous filament nonwoven fabric and the articles thereof
EP1687480B1 (en) * 2003-10-22 2011-06-08 E.I. Du Pont De Nemours And Company Porous fibrous sheets of nanofibers
US8470722B2 (en) * 2006-11-03 2013-06-25 E I Du Pont De Nemours And Company Breathable waterproof fabrics with a dyed and welded microporous layer
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers
BRPI0820145A2 (en) * 2007-11-13 2015-05-12 Du Pont "clothing"
GB0817926D0 (en) * 2008-10-01 2008-11-05 Quantum Clothing Ltd Articles of clothiing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720415A (en) * 1985-07-30 1988-01-19 Kimberly-Clark Corporation Composite elastomeric material and process for making the same
US6114017A (en) * 1997-07-23 2000-09-05 Fabbricante; Anthony S. Micro-denier nonwoven materials made using modular die units

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3824625A (en) * 1971-06-30 1974-07-23 Kimberly Clark Co Disposable gown with multiple flaps and closures
GB1453447A (en) * 1972-09-06 1976-10-20 Kimberly Clark Co Nonwoven thermoplastic fabric
US3934582A (en) * 1974-01-02 1976-01-27 Johnson & Johnson Surgical wrap
US3935596A (en) * 1974-11-06 1976-02-03 Johnson & Johnson Surgical gown with transfer device
US4166464A (en) * 1976-06-23 1979-09-04 Johnson & Johnson Absorbent dressing
US4290148A (en) * 1980-03-14 1981-09-22 Roberts Fred A Surgical gown
US5225018A (en) * 1989-11-08 1993-07-06 Fiberweb North America, Inc. Method and apparatus for providing uniformly distributed filaments from a spun filament bundle and spunbonded fabric obtained therefrom
US5679379A (en) * 1995-01-09 1997-10-21 Fabbricante; Anthony S. Disposable extrusion apparatus with pressure balancing modular die units for the production of nonwoven webs
US5783503A (en) * 1996-07-22 1998-07-21 Fiberweb North America, Inc. Meltspun multicomponent thermoplastic continuous filaments, products made therefrom, and methods therefor
US6191211B1 (en) * 1998-09-11 2001-02-20 The Dow Chemical Company Quick-set film-forming compositions
AU6429899A (en) * 1998-10-16 2000-05-08 Exxon Chemical Patents Inc. Process for producing polyolefin microporous breathable film
IL161954A0 (en) * 2001-11-16 2005-11-20 Polymer Group Inc Non-woven barrier fabrics
CN1700897A (en) * 2002-09-18 2005-11-23 帕里莫集团有限公司 Barrier performance of absorbent article components
EP1549790A4 (en) * 2002-09-19 2007-01-31 Polymer Group Inc Nonwoven industrial fabrics with improved barrier properties

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720415A (en) * 1985-07-30 1988-01-19 Kimberly-Clark Corporation Composite elastomeric material and process for making the same
US6114017A (en) * 1997-07-23 2000-09-05 Fabbricante; Anthony S. Micro-denier nonwoven materials made using modular die units

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1549161A2 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658548B2 (en) 2002-09-17 2014-02-25 E I Du Pont De Nemours And Company Extremely high liquid barrier fabrics
DE202011103351U1 (en) 2011-04-28 2011-11-02 Česká Včela s.r.o. barrier textiles
RU2473428C1 (en) * 2011-04-28 2013-01-27 ЧЕСКА ВЧЕЛА с.р.о. Barrier fabric

Also Published As

Publication number Publication date
EP1549161A2 (en) 2005-07-06
MXPA05003031A (en) 2005-05-27
US20040128732A1 (en) 2004-07-08
CN1700865A (en) 2005-11-23
US20060264131A1 (en) 2006-11-23
WO2004026055A3 (en) 2005-05-12
EP1549161A4 (en) 2006-11-22
JP2005539158A (en) 2005-12-22
AU2003275082A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
US20040116019A1 (en) Nonwoven industrial fabrics with improved barrier properties
US20060264131A1 (en) Medical fabrics with improved barrier performance
US20060128249A1 (en) Hydroentangled continuous filament nonwoven fabric and the articles thereof
US20030129909A1 (en) Nonwoven barrier fabrics with enhanced barrier to weight performance
EP1423250B1 (en) Thermoplastic constructs with improved softness
AU2002355421A1 (en) Thermoplastic constructs with improved softness
US20050020159A1 (en) Hydroentangled continuous filament nonwoven fabric and the articles thereof
US20040133177A1 (en) Barrier performance of absorbent article components
US6878648B2 (en) Regionally imprinted nonwoven fabric
US20040142622A1 (en) Nonwoven barrier fabric comprising frangible fibrous component
US20030137076A1 (en) Bondable thermoplastic constructs with improved wettability

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 167505

Country of ref document: IL

Ref document number: 2003759352

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/003031

Country of ref document: MX

Ref document number: 2004538352

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003275082

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 20038252597

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2003759352

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003759352

Country of ref document: EP